Net Income (Loss) Attributable to Parent in USD of Applied Therapeutics, Inc. from Q1 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Applied Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q1 2018 to Q3 2025.
  • Applied Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$19M, a 72.3% increase year-over-year.
  • Applied Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$18.1M, a 90.3% increase year-over-year.
  • Applied Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$106M, a 11.8% increase from 2023.
  • Applied Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$120M, a 45.2% decline from 2022.
  • Applied Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$82.5M, a 21.9% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Applied Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$18.1M -$19M +$49.6M +72.3% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 -$67.7M -$21.3M -$24.2M -836% 01 Apr 2025 30 Jun 2025 10-Q 13 Nov 2025
Q1 2025 -$43.5M -$21.8M +$62.1M +74% 01 Jan 2025 31 Mar 2025 10-Q 13 Nov 2025
Q4 2024 -$106M $44M +$81.7M 01 Oct 2024 31 Dec 2024 10-K 15 Apr 2025
Q3 2024 -$187M -$68.6M -$26.2M -61.9% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025
Q2 2024 -$161M $2.9M +$32.5M 01 Apr 2024 30 Jun 2024 10-Q 13 Nov 2025
Q1 2024 -$194M -$83.9M -$73.8M -728% 01 Jan 2024 31 Mar 2024 10-Q 13 Nov 2025
Q4 2023 -$120M -$37.7M -$23.3M -161% 01 Oct 2023 31 Dec 2023 10-K 15 Apr 2025
Q3 2023 -$96.5M -$42.4M -$23.3M -122% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 -$73.2M -$29.6M -$3.72M -14.4% 01 Apr 2023 30 Jun 2023 10-Q 07 Nov 2024
Q1 2023 -$69.5M -$10.1M +$13M +56.2% 01 Jan 2023 31 Mar 2023 10-Q 07 Nov 2024
Q4 2022 -$82.5M -$14.4M +$12.7M +46.9% 01 Oct 2022 31 Dec 2022 10-K 06 Mar 2024
Q3 2022 -$95.2M -$19.1M +$9.32M +32.8% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 -$105M -$25.9M -$29K -0.11% 01 Apr 2022 30 Jun 2022 10-Q 09 Nov 2023
Q1 2022 -$105M -$23.1M +$1.06M +4.38% 01 Jan 2022 31 Mar 2022 10-Q 09 Nov 2023
Q4 2021 -$106M -$27.2M -$3.47M -14.6% 01 Oct 2021 31 Dec 2021 10-K 23 Mar 2023
Q3 2021 -$102M -$28.4M +$1.43M +4.78% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 -$104M -$25.8M +$2.23M +7.95% 01 Apr 2021 30 Jun 2021 10-Q 09 Nov 2022
Q1 2021 -$106M -$24.2M -$11.8M -95.5% 01 Jan 2021 31 Mar 2021 10-Q 09 Nov 2022
Q4 2020 -$94M -$23.7M -$6.06M -34.3% 01 Oct 2020 31 Dec 2020 10-K 10 Mar 2022
Q3 2020 -$87.9M -$29.8M -$19.1M -179% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021
Q2 2020 -$68.8M -$28.1M -$19.6M -233% 01 Apr 2020 30 Jun 2020 10-Q 12 Nov 2021
Q1 2020 -$49.2M -$12.4M -$3.64M -41.7% 01 Jan 2020 31 Mar 2020 10-Q 12 Nov 2021
Q4 2019 -$45.5M -$17.6M -$10.9M -162% 01 Oct 2019 31 Dec 2019 10-K 18 Mar 2021
Q3 2019 -$34.6M -$10.7M -$6.43M -150% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020
Q2 2019 -$28.2M -$8.44M -$5.25M -165% 01 Apr 2019 30 Jun 2019 10-Q 12 Nov 2020
Q1 2019 -$22.9M -$8.73M -$6.4M -274% 01 Jan 2019 31 Mar 2019 10-Q 12 Nov 2020
Q4 2018 -$16.5M -$6.72M 01 Oct 2018 31 Dec 2018 10-K 13 Mar 2020
Q3 2018 -$4.28M 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2019
Q2 2018 -$3.19M 01 Apr 2018 30 Jun 2018 10-Q 13 Nov 2019
Q1 2018 -$2.34M 01 Jan 2018 31 Mar 2018 10-Q 13 Nov 2019

Applied Therapeutics, Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$106M +$14.1M +11.8% 01 Jan 2024 31 Dec 2024 10-K 15 Apr 2025
2023 -$120M -$37.3M -45.2% 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2025
2022 -$82.5M +$23.1M +21.9% 01 Jan 2022 31 Dec 2022 10-K 06 Mar 2024
2021 -$106M -$11.6M -12.4% 01 Jan 2021 31 Dec 2021 10-K 23 Mar 2023
2020 -$94M -$48.4M -106% 01 Jan 2020 31 Dec 2020 10-K 10 Mar 2022
2019 -$45.5M -$29M -175% 01 Jan 2019 31 Dec 2019 10-K 18 Mar 2021
2018 -$16.5M 01 Jan 2018 31 Dec 2018 10-K 13 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.